{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:58:53Z","timestamp":1791496733777,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001777","name":"University of Wollongong","doi-asserted-by":"publisher","award":["M2024"],"award-info":[{"award-number":["M2024"]}],"id":[{"id":"10.13039\/501100001777","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1194872"],"award-info":[{"award-number":["1194872"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1194872"],"award-info":[{"award-number":["APP1194872"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2021010"],"award-info":[{"award-number":["APP2021010"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016887","name":"Motor Neurone Disease Research Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014012","name":"Cure For MND Foundation Inc","doi-asserted-by":"publisher","award":["DDG-159"],"award-info":[{"award-number":["DDG-159"]}],"id":[{"id":"10.13039\/100014012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ebiom.2025.105692","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:36:17Z","timestamp":1744479377000},"page":"105692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A polytherapy approach demonstrates therapeutic efficacy for the treatment of SOD1 associated amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2133-9308","authenticated-orcid":false,"given":"Jeremy S.","family":"Lum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikayla L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E.","family":"Farrawell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christen G.","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3575-0106","authenticated-orcid":false,"given":"Anthony","family":"Dosseto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3275-710X","authenticated-orcid":false,"given":"Florian","family":"Dux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachlan E.","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath","family":"Ecroyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"McAlary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5373-0080","authenticated-orcid":false,"given":"Paul S.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin J.","family":"Yerbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105692_bib1","first-page":"49","article-title":"The genetics of amyotrophic lateral sclerosis: current insights","volume":"6","author":"Alsultan","year":"2016","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105692_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/humu.22157","article-title":"ALSoD: a user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics","volume":"33","author":"Abel","year":"2012","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105692_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000350","article-title":"An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans","volume":"5","author":"Wang","year":"2009","journal-title":"PLoS Genet"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105692_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023561","article-title":"In-cell NMR in E. coli to monitor maturation steps of hSOD1","volume":"6","author":"Banci","year":"2011","journal-title":"PLoS One"},{"issue":"37","key":"10.1016\/j.ebiom.2025.105692_bib5","doi-asserted-by":"crossref","first-page":"23625","DOI":"10.1074\/jbc.273.37.23625","article-title":"The copper chaperone CCS directly interacts with copper\/zinc superoxide dismutase","volume":"273","author":"Casareno","year":"1998","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105692_bib6","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.4103\/1673-5374.255962","article-title":"Strategies to promote the maturation of ALS-associated SOD1 mutants: small molecules return to the fold","volume":"14","author":"McAlary","year":"2019","journal-title":"Neural Regen Res"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105692_bib7","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1074\/jbc.M705957200","article-title":"Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide","volume":"283","author":"Donnelly","year":"2008","journal-title":"J Biol Chem"},{"issue":"51","key":"10.1016\/j.ebiom.2025.105692_bib8","doi-asserted-by":"crossref","first-page":"44035","DOI":"10.1074\/jbc.M111.274407","article-title":"Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model","volume":"286","author":"Soon","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2025.105692_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ibror.2017.03.001","article-title":"CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits","volume":"2","author":"Vieira","year":"2017","journal-title":"IBRO Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105692_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/srep42292","article-title":"CuII(atsm) improves the neurological phenotype and survival of SOD1G93A mice and selectively increases enzymatically active SOD1 in the spinal cord","volume":"7","author":"Hilton","year":"2017","journal-title":"Sci Rep"},{"issue":"23","key":"10.1016\/j.ebiom.2025.105692_bib11","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1523\/JNEUROSCI.4196-13.2014","article-title":"Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis","volume":"34","author":"Roberts","year":"2014","journal-title":"J Neurosci"},{"issue":"7\u20138","key":"10.1016\/j.ebiom.2025.105692_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/21678421.2013.824000","article-title":"Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis","volume":"14","author":"McAllum","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105692_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98317-w","article-title":"CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1G93A mice with a C57BL\/6 background","volume":"11","author":"Lum","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105692_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111751","article-title":"Mechanisms of IRF2BPL-related disorders and identification of a potential therapeutic strategy","volume":"41","author":"Sinha Ray","year":"2022","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105692_bib15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/glia.24278","article-title":"CuATSM effectively ameliorates ALS patient astrocyte-mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis","volume":"71","author":"Dennys","year":"2023","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105692_bib16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/bph.14881","article-title":"CuII(atsm) inhibits ferroptosis: implications for treatment of neurodegenerative disease","volume":"177","author":"Southon","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2025.105692_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13024-023-00691-8","article-title":"Microglial ferroptotic stress causes non-cell autonomous neuronal death","volume":"19","author":"Liddell","year":"2024","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.ebiom.2025.105692_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.01.020","article-title":"Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD","volume":"89","author":"Williams","year":"2016","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105692_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101612","article-title":"A copper chaperone\u2013mimetic polytherapy for SOD1-associated amyotrophic lateral sclerosis","volume":"298","author":"McAlary","year":"2022","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105692_bib20","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acschemneuro.8b00527","article-title":"CuATSM protects against the in vitro cytotoxicity of wild-type-like copper\u2013zinc superoxide dismutase mutants but not mutants that disrupt metal binding","volume":"10","author":"Farrawell","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.ebiom.2025.105692_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102980","article-title":"Novel Selenium-based compounds with therapeutic potential for SOD1-linked amyotrophic lateral sclerosis","author":"Amporndanai","year":"2020","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105692_bib22","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41467-018-04114-x","article-title":"The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation","volume":"9","author":"Capper","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105692_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.nbd.2018.11.025","article-title":"Tryptophan 32 mediates SOD1 toxicity in a in vivo motor neuron model of ALS and is a promising target for small molecule therapeutics","volume":"124","author":"DuVal","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105692_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32835-y","article-title":"Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells","volume":"8","author":"Pokrishevsky","year":"2018","journal-title":"Sci Rep"},{"issue":"22","key":"10.1016\/j.ebiom.2025.105692_bib25","doi-asserted-by":"crossref","first-page":"16329","DOI":"10.1074\/jbc.M610119200","article-title":"Tryptophan 32 potentiates aggregation and cytotoxicity of a copper\/zinc superoxide dismutase mutant associated with familial amyotrophic lateral sclerosis\u2217","volume":"282","author":"Taylor","year":"2007","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105692_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227655","article-title":"Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection","volume":"15","author":"Crown","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105692_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1523\/JNEUROSCI.4253-04.2005","article-title":"Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis","volume":"25","author":"Turner","year":"2005","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105692_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/aja.1001940306","article-title":"Neuroblastoma \u00d7 spinal cord (NSC) hybrid cell lines resemble developing motor neurons","volume":"194","author":"Cashman","year":"1992","journal-title":"Dev Dyn"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105692_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126479","article-title":"Three dimensional checkerboard synergy analysis of colistin, meropenem, tigecycline against multidrug-resistant clinical Klebsiella pneumonia isolates","volume":"10","author":"Stein","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.105692_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00499","article-title":"Susceptibility of mutant SOD1 to form a destabilized monomer predicts cellular aggregation and toxicity but not in vitro aggregation propensity","volume":"10","author":"McAlary","year":"2016","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105692_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101748","article-title":"Assessment of protein inclusions in cultured cells using automated image analysis","volume":"3","author":"McAlary","year":"2022","journal-title":"STAR Protoc"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105692_bib32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105692_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0003-2697(71)90370-8","article-title":"Superoxide dismutase: improved assays and an assay applicable to acrylamide gels","volume":"44","author":"Beauchamp","year":"1971","journal-title":"Anal Biochem"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105692_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/17482960701856300","article-title":"Design, power, and interpretation of studies in the standard murine model of ALS","volume":"9","author":"Scott","year":"2008","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.ebiom.2025.105692_bib35","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1039\/B307499D","article-title":"Structural trends in copper(II) bis(thiosemicarbazone) radiopharmaceuticals","volume":"23","author":"Blower","year":"2003","journal-title":"Dalton Trans"},{"key":"10.1016\/j.ebiom.2025.105692_bib36","article-title":"A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS","volume":"104","author":"Hatzipetros","year":"2015","journal-title":"J Vis Exp"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105692_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056257","article-title":"Genetic deficiency of GABA differentially regulates respiratory and non-respiratory motor neuron development","volume":"8","author":"Fogarty","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.ebiom.2025.105692_bib38","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1021\/acschemneuro.2c00253","article-title":"Cells overexpressing ALS-associated SOD1 variants are differentially susceptible to CuATSM-associated toxicity","volume":"13","author":"Brown","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.ebiom.2025.105692_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2018.02.002","article-title":"Light-induced oxidant production by fluorescent proteins","volume":"128","author":"Trewin","year":"2018","journal-title":"Free Radic Biol Med"},{"issue":"14","key":"10.1016\/j.ebiom.2025.105692_bib40","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1038\/sj.emboj.7600276","article-title":"Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS","volume":"23","author":"Furukawa","year":"2004","journal-title":"EMBO J"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105692_bib41","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3109\/00498258809042259","article-title":"A novel biologically active selenoorganic compound. VIII. Biotransformation of ebselen","volume":"18","author":"Fischer","year":"1988","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ebiom.2025.105692_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-0028-1111106","article-title":"Development of ebselen, a glutathione peroxidase mimic, for the prevention and treatment of noise-induced hearing loss","volume":"30","author":"Lynch","year":"2009","journal-title":"Semin Hear"},{"key":"10.1016\/j.ebiom.2025.105692_bib43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/cc13804","article-title":"Criticizing reporting standards fails to improve quality in animal research","volume":"18","author":"Otto","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.ebiom.2025.105692_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/2051-5960-2-55","article-title":"Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases","volume":"2","author":"Ayers","year":"2014","journal-title":"Acta Neuropathol Commun"},{"issue":"14","key":"10.1016\/j.ebiom.2025.105692_bib45","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1073\/pnas.1115009109","article-title":"Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS","volume":"109","author":"Brotherton","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105692_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-62903-5","article-title":"Ebselen analogues delay disease onset and its course in fALS by on-target SOD-1 engagement","volume":"14","author":"Watanabe","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105692_bib47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s12010-019-03114-x","article-title":"Elucidation of the molecular characteristics of wild-type and ALS-linked mutant SOD1 using the NanoLuc complementation reporter system","volume":"190","author":"Oh-hashi","year":"2020","journal-title":"Appl Biochem Biotechnol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105692_bib48","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1128\/AAC.00029-08","article-title":"Nonclinical safety profile of telbivudine, a novel potent antiviral agent for treatment of hepatitis B","volume":"52","author":"Bridges","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105692_bib49","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.bjp.0704808","article-title":"Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cells","volume":"136","author":"Yoshizumi","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2025.105692_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neures.2020.05.009","article-title":"Neuroprotective effect of CuATSM in mice stroke model by ameliorating oxidative stress","volume":"166","author":"Shi","year":"2021","journal-title":"Neurosci Res"},{"key":"10.1016\/j.ebiom.2025.105692_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114444","article-title":"Ebselen alleviates white matter lesions and improves cognitive deficits by attenuating oxidative stress via Keap1\/Nrf2 pathway in chronic cerebral hypoperfusion mice","volume":"448","author":"Dong","year":"2023","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105692_bib52","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1007\/s13311-021-01111-9","article-title":"Characterization of selenium compounds for anti-ferroptotic activity in neuronal cells and after cerebral ischemia\u2013reperfusion injury","volume":"18","author":"Tuo","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105692_bib53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/life10110271","article-title":"Copper-ATSM as a treatment for ALS: support from mutant SOD1 models and beyond","volume":"10","author":"Nikseresht","year":"2020","journal-title":"Life"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105692_bib54","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1172\/JCI99081","article-title":"Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models","volume":"128","author":"McCampbell","year":"2018","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105692_bib55","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/17460441.2018.1533953","article-title":"High-throughput drug screens for amyotrophic lateral sclerosis drug discovery","volume":"13","author":"McGown","year":"2018","journal-title":"Expert Opin Drug Discov"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105692_bib56","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"New Engl J Med"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:38:40Z","timestamp":1778873920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425001367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":56,"alternative-id":["S2352396425001367"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105692","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A polytherapy approach demonstrates therapeutic efficacy for the treatment of SOD1 associated amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105692"}}